Authors:
Briones, M
Singh, M
Ugozzoli, M
Kazzaz, J
Klakamp, S
Ott, G
O'Hagan, D
Citation: M. Briones et al., The preparation, characterization, and evaluation of cationic microparticles for DNA vaccine delivery, PHARM RES, 18(5), 2001, pp. 709-712
Authors:
Singh, M
Ott, G
Kazzaz, J
Ugozzoli, M
Briones, M
Donnelly, J
O'Hagan, DT
Citation: M. Singh et al., Cationic microparticles are an effective delivery system for immune stimulatory CpG DNA, PHARM RES, 18(10), 2001, pp. 1476-1479
Authors:
O'Hagan, D
Singh, M
Ugozzoli, M
Wild, C
Barnett, S
Chen, MC
Schaefer, M
Doe, B
Otten, GR
Ulmer, JB
Citation: D. O'Hagan et al., Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines, J VIROLOGY, 75(19), 2001, pp. 9037-9043
Authors:
Ugozzoli, M
Santos, G
Donnelly, J
O'Hagan, DT
Citation: M. Ugozzoli et al., Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant, J INFEC DIS, 183(2), 2001, pp. 351-354
Authors:
Greer, CE
Petracca, R
Buonamassa, DT
Di Tommaso, A
Gervase, B
Reeve, RL
Ugozzoli, M
Van Nest, G
De Magistris, MT
Bensi, G
Citation: Ce. Greer et al., The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles, VACCINE, 19(9-10), 2000, pp. 1008-1012
Authors:
O'Hagan, DT
Ugozzoli, M
Barackman, J
Singh, M
Kazzaz, J
Higgins, K
Vancott, TC
Ott, G
Citation: Dt. O'Hagan et al., Microparticles in MF59, a potent adjuvant combination for a recombinant protein vaccine against HIV-1, VACCINE, 18(17), 2000, pp. 1793-1801
Authors:
Neidleman, JA
Vajdy, M
Ugozzoli, M
Ott, G
O'Hagan, D
Citation: Ja. Neidleman et al., Genetically detoxified mutants of heat-labile enterotoxin from Escherichiacoli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55, IMMUNOLOGY, 101(1), 2000, pp. 154-160
Authors:
O'Hagan, D
Goldbeck, C
Ugozzoli, M
Ott, G
Burke, RL
Citation: D. O'Hagan et al., Intranasal immunization with recombinant gD2 reduces disease severity and mortality following genital challenge with herpes simplex virus type 2 in guinea pigs, VACCINE, 17(18), 1999, pp. 2229-2236